ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

IOM Report Recommends Solutions to Problem of Medication Errors.

July 28, 2006

ONS Votes to Push Congress on DRGs

June 1, 1984

Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years

September 28, 2012

In Brief: Gori to Return As Head Of Smoking Program; Wisconsin, AACI To Honor Harold Rusch

May 18, 1979

NCI Expects Improved Communications to Result from Consolidation of Offices

May 12, 2000